{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:55:42Z","timestamp":1781650542392,"version":"3.54.5"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system. In this disease, mitochondrial dysfunction contributes to neurodegeneration, axonal loss, and progressive disability. Extracellular vesicle (EV)-mediated mitochondrial transfer has emerged as a promising cell-free strategy to restore mitochondrial homeostasis and modulate immune responses within the CNS. Preclinical studies, particularly in experimental autoimmune encephalomyelitis models, demonstrate that EV-based delivery of mitochondrial cargo improves cellular bioenergetics. In parallel, this approach reduces oxidative stress and neuroinflammation while supporting remyelination and neuroprotection. This review summarizes the mechanistic rationale, current preclinical evidence, and future translational perspectives of EV-mediated mitochondrial therapy in MS.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>Schematic illustration showing the dual role of neuronal\u2013microglial interaction under pathological and therapeutic conditions. (Left) Neuronal injury caused by oxidative stress, reduced ATP production, and reactive oxygen species (ROS) results in mitochondrial damage and the release of mtDNA, which is taken up by microglia, leading to microglial activation and neuroinflammation. (Right) Under therapeutic conditions, extracellular vesicle (EV)-mediated transfer of mitochondrial components or protective factors restores mitochondrial function, reduces neuroinflammation, and promotes neuronal recovery<\/jats:p>","DOI":"10.1007\/s10571-026-01716-8","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:57:10Z","timestamp":1776434230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial-Immune Dysfunction in MS: Therapeutic Potential of EV-Mediated Transfer"],"prefix":"10.1007","volume":"46","author":[{"given":"Parsa","family":"Navazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fereidouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4348-272X","authenticated-orcid":false,"given":"Nafiseh","family":"Erfanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"8","key":"1716_CR1","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1111\/ejn.16541","volume":"60","author":"E Akyuz","year":"2024","unstructured":"Akyuz E, Aslan FS, Gokce E, Ilmaz O, Topcu F, Kakac S (2024) Extracellular vesicle and CRISPR gene therapy: current applications in Alzheimer\u2019s disease, Parkinson\u2019s disease, amyotrophic lateral sclerosis, and Huntington\u2019s disease. Eur J Neurosci 60(8):6057\u20136090","journal-title":"Eur J Neurosci"},{"issue":"5","key":"1716_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/brain\/awae409","volume":"148","author":"G Androdias","year":"2025","unstructured":"Androdias G, L\u00fcnemann JD, Maillart E, Amato MP, Audoin B, Bruijstens AL, Bsteh G, Butzkueven H, Ciccarelli O, Cobo-Calvo A (2025) De-escalating and discontinuing disease-modifying therapies in multiple sclerosis. Brain 148(5):1459\u20131478","journal-title":"Brain"},{"key":"1716_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2025.106992","volume":"274","author":"V Artusa","year":"2025","unstructured":"Artusa V, De Luca L, Clerici M, Trabattoni D (2025) Connecting the dots: mitochondrial transfer in immunity, inflammation, and cancer. Immunol Lett 274:106992","journal-title":"Immunol Lett"},{"issue":"1","key":"1716_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12974-023-02971-y","volume":"20","author":"G Ayyubova","year":"2023","unstructured":"Ayyubova G, Kodali M, Upadhya R, Madhu LN, Attaluri S, Somayaji Y, Shuai B, Rao S, Shankar G, Shetty AK (2023) Extracellular vesicles from hiPSC-NSCs can prevent peripheral inflammation-induced cognitive dysfunction with inflammasome inhibition and improved neurogenesis in the hippocampus. J Neuroinflamm 20(1):297","journal-title":"J Neuroinflamm"},{"key":"1716_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biology8020037","author":"IP Barcelos","year":"2019","unstructured":"Barcelos IP, Troxell RM, Graves JS (2019) Mitochondrial dysfunction and multiple sclerosis. Biology. https:\/\/doi.org\/10.3390\/biology8020037","journal-title":"Biology"},{"key":"1716_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/alz.086909","volume":"20","author":"G Baudo","year":"2024","unstructured":"Baudo G (2024) Mitochondrial replenishment as a treatment for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 20:e086909","journal-title":"Alzheimer's Dement"},{"issue":"21","key":"1716_CR7","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.3390\/ijms232112725","volume":"23","author":"AV Blagov","year":"2022","unstructured":"Blagov AV, Sukhorukov VN, Orekhov AN, Sazonova MA, Melnichenko AA (2022) Significance of mitochondrial dysfunction in the progression of multiple sclerosis. Int J Mol Sci 23(21):12725","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1716_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ana.27165","volume":"97","author":"MR Brier","year":"2025","unstructured":"Brier MR, Judge B, Ying C, Salter A, An H, Patel A, Wang Q, Wang Y, Cross AH, Naismith RT (2025) Increased white matter aerobic glycolysis in multiple sclerosis. Ann Neurol 97(4):766\u2013778","journal-title":"Ann Neurol"},{"key":"1716_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jns.2017.12.004","volume":"385","author":"T Bunai","year":"2018","unstructured":"Bunai T, Terada T, Kono S, Yokokura M, Yoshikawa E, Futatsubashi M, Miyajima H, Ouchi Y (2018) Neuroinflammation following disease modifying therapy in multiple sclerosis: a pilot positron emission tomography study. J Neurol Sci 385:30\u201333","journal-title":"J Neurol Sci"},{"key":"1716_CR10","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s225453","author":"T Burnouf","year":"2019","unstructured":"Burnouf T, Agrahari V, Agrahari V (2019) Extracellular vesicles as nanomedicine: hopes and hurdles in clinical translation. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/ijn.s225453","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1716_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-019-1526-0","volume":"16","author":"M Castellazzi","year":"2019","unstructured":"Castellazzi M, Patergnani S, Donadio M, Giorgi C, Bonora M, Fainardi E, Casetta I, Granieri E, Pugliatti M, Pinton P (2019) Correlation between auto\/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients. J Neuroinflammation 16(1):131","journal-title":"J Neuroinflammation"},{"issue":"25","key":"1716_CR11","doi-asserted-by":"publisher","first-page":"e2421806122","DOI":"10.1073\/pnas.2421806122","volume":"122","author":"K C Atkinson","year":"2025","unstructured":"C Atkinson K, Desfor S, Feri M, Sekyi T M, Osunde M, Sriram S, Noori S, Rinc\u00f3n W, Bello B, Tiwari-Woodruff K S (2025) Decreased mitochondrial activity in the demyelinating cerebellum of progressive multiple sclerosis and chronic EAE contributes to Purkinje cell loss. Proc Natl Acad Sci 122(25):e2421806122","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"1716_CR13","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.4103\/NRR.NRR-D-24-00243","volume":"20","author":"J Chen","year":"2025","unstructured":"Chen J, Li Y, Quan X, Chen J, Han Y, Yang L, Zhou M, Mok GSP, Wang R, Zhao Y (2025a) Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery. Neural Regeneration Res 20(8):2181\u20132198","journal-title":"Neural Regeneration Res"},{"key":"1716_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105605","author":"J Chen","year":"2025","unstructured":"Chen J, Tian C, Xiong X, Yang Y, Zhang J (2025b) Extracellular vesicles: new horizons in neurodegeneration. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105605","journal-title":"EBioMedicine"},{"issue":"1","key":"1716_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.33594\/000000116","volume":"27","author":"F Ciccocioppo","year":"2019","unstructured":"Ciccocioppo F, Lanuti P, Centonze D, Miscia S, Marchisio M (2019) The link among neurological diseases: extracellular vesicles as a possible brain injury footprint. Neurosignals 27(1):25\u201339","journal-title":"Neurosignals"},{"issue":"10","key":"1716_CR16","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.3390\/ijms24108848","volume":"24","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Mart\u00edn-Rodr\u00edguez A, Y\u00e1\u00f1ez-Sep\u00falveda R, Tornero-Aguilera JF (2023) Mitochondrial transfer as a novel therapeutic approach in disease diagnosis and treatment. Int J Mol Sci 24(10):8848","journal-title":"Int J Mol Sci"},{"key":"1716_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15674","author":"S Colja","year":"2023","unstructured":"Colja S, Jov\u010devska I, \u0160amec N, Zottel A (2023) Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15674","journal-title":"Heliyon"},{"issue":"9648","key":"1716_CR18","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502\u20131517","journal-title":"Lancet"},{"key":"1716_CR19","doi-asserted-by":"publisher","first-page":"894298","DOI":"10.3389\/fnmol.2022.894298","volume":"15","author":"Y Cui","year":"2022","unstructured":"Cui Y, Yu H, Bu Z, Wen L, Yan L, Feng J (2022) Focus on the role of the NLRP3 inflammasome in multiple sclerosis: pathogenesis, diagnosis, and therapeutics. Front Mol Neurosci 15:894298","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"1716_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071733","volume":"10","author":"M D\u2019Anca","year":"2021","unstructured":"D\u2019Anca M, Fenoglio C, Buccellato FR, Visconte C, Galimberti D, Scarpini E (2021) Extracellular vesicles in multiple sclerosis: role in the pathogenesis and potential usefulness as biomarkers and therapeutic tools. Cells 10(7):1733","journal-title":"Cells"},{"issue":"17","key":"1716_CR22","doi-asserted-by":"publisher","first-page":"13247","DOI":"10.3390\/ijms241713247","volume":"24","author":"AA Danilushkina","year":"2023","unstructured":"Danilushkina AA, Emene CC, Barlev NA, Gomzikova MO (2023) Strategies for engineering of extracellular vesicles. Int J Mol Sci 24(17):13247","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1716_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12195-022-00738-8","volume":"15","author":"KM Dave","year":"2022","unstructured":"Dave KM, Dobbins DX, Farinelli MN, Sullivan A, Milosevic J, Stolz DB, Kim J, Zheng S, Manickam DS (2022) Engineering extracellular vesicles to modulate their innate mitochondrial load. Cell Mol Bioeng 15(5):367\u2013389","journal-title":"Cell Mol Bioeng"},{"issue":"9","key":"1716_CR24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1716_CR25","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/s41418-021-00766-3","volume":"28","author":"A Di Rita","year":"2021","unstructured":"Di Rita A, Angelini DF, Maiorino T, Caputo V, Cascella R, Kumar M, Tiberti M, Lambrughi M, Wesch N, L\u00f6hr F (2021) Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Cell Death Different 28(8):2499\u20132516","journal-title":"Cell Death Different"},{"key":"1716_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2021.08.038","volume":"338","author":"A D\u2019Souza","year":"2021","unstructured":"D\u2019Souza A, Burch A, Dave KM, Sreeram A, Reynolds MJ, Dobbins DX, Kamte YS, Zhao W, Sabatelle C, Joy GM (2021) Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells. J Control Release 338:505\u2013526","journal-title":"J Control Release"},{"issue":"11","key":"1716_CR26","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1007\/s12035-023-03472-y","volume":"60","author":"M Dubowsky","year":"2023","unstructured":"Dubowsky M, Theunissen F, Carr JM, Rogers M-L (2023) The molecular link between TDP-43, endogenous retroviruses and inflammatory neurodegeneration in amyotrophic lateral sclerosis: a potential target for Triumeq, an antiretroviral therapy. Mol Neurobiol 60(11):6330\u20136345","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1716_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20736","volume":"59","author":"R Dutta","year":"2006","unstructured":"Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59(3):478\u2013489","journal-title":"Ann Neurol"},{"issue":"4","key":"1716_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11481-014-9544-2","volume":"9","author":"P Faria Dde","year":"2014","unstructured":"Faria Dde P, Copray S, Buchpiguel C, Dierckx R, de Vries E (2014) PET imaging in multiple sclerosis. J Neuroimmune Pharmacol 9(4):468\u2013482","journal-title":"J Neuroimmune Pharmacol"},{"key":"1716_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2019.09.059","volume":"49","author":"X Feng","year":"2019","unstructured":"Feng X, Bao R, Li L, Deisenhammer F, Arnason BG, Reder AT (2019) Interferon-\u03b2 corrects massive gene dysregulation in multiple sclerosis: short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine 49:269\u2013283","journal-title":"EBioMedicine"},{"issue":"9","key":"1716_CR30","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1080\/15548627.2022.2092315","volume":"18","author":"JV Ferreira","year":"2022","unstructured":"Ferreira JV, da Rosa Soares A, Pereira P (2022) LAMP2A mediates the loading of proteins into endosomes and selects exosomal cargo. Autophagy 18(9):2263\u20132265","journal-title":"Autophagy"},{"issue":"7399","key":"1716_CR109","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U F\u00fcnfschilling","year":"2012","unstructured":"F\u00fcnfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, M\u00f6bius W (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485(7399):517\u2013521","journal-title":"Nature"},{"issue":"4","key":"1716_CR31","first-page":"203","volume":"20","author":"I Fyfe","year":"2024","unstructured":"Fyfe I (2024) Mitochondrial DNA marks multiple sclerosis. Nat Rev Neurol 20(4):203\u2013203","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1716_CR32","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2017.09.039","volume":"171","author":"MM Gaidt","year":"2017","unstructured":"Gaidt MM, Ebert TS, Chauhan D, Ramshorn K, Pinci F, Zuber S, O\u2019Duill F, Schmid-Burgk JL, Hoss F, Buhmann R (2017) The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell 171(5):1110-1124. e1118","journal-title":"Cell"},{"issue":"11","key":"1716_CR33","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1111\/cns.14344","volume":"29","author":"Z Geng","year":"2023","unstructured":"Geng Z, Guan S, Wang S, Yu Z, Liu T, Du S, Zhu C (2023) Intercellular mitochondrial transfer in the brain, a new perspective for targeted treatment of central nervous system diseases. CNS Neurosci Ther 29(11):3121\u20133135","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"1716_CR34","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s40120-023-00535-z","volume":"12","author":"A Ghezzi","year":"2023","unstructured":"Ghezzi A, Neuteboom R (2023) Neurofilament light chain in adult and pediatric multiple sclerosis: a promising biomarker to better characterize disease activity and personalize MS treatment. Neurol Ther 12(6):1867\u20131881","journal-title":"Neurol Ther"},{"issue":"7","key":"1716_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073424","volume":"26","author":"MA Grignano","year":"2025","unstructured":"Grignano MA, Pisani S, Gregorini M, Rainaudo G, Avanzini MA, Croce S, Valsecchi C, Ceccarelli G, Islami T, Margiotta E (2025) Engineered ATP-loaded extracellular vesicles derived from mesenchymal stromal cells: a novel strategy to counteract cell ATP depletion in an in vitro model. Int J Mol Sci 26(7):3424","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1716_CR36","doi-asserted-by":"publisher","first-page":"e1715","DOI":"10.1016\/S2214-109X(22)00429-6","volume":"10","author":"A Haakenstad","year":"2022","unstructured":"Haakenstad A, Yearwood JA, Fullman N, Bintz C, Bienhoff K, Weaver MR, Nandakumar V, LeGrand KE, Knight M, Abbafati C (2022) Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Glob Health 10(12):e1715\u2013e1743","journal-title":"Lancet Glob Health"},{"key":"1716_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1290666","volume":"14","author":"H-P Hartung","year":"2023","unstructured":"Hartung H-P, Cree BA, Barnett M, Meuth SG, Bar-Or A, Steinman L (2023) Bioavailable central nervous system disease-modifying therapies for multiple sclerosis. Front Immunol 14:1290666","journal-title":"Front Immunol"},{"key":"1716_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122668","volume":"347","author":"N Hasaniani","year":"2024","unstructured":"Hasaniani N, Nouri S, Shirzad M, Rostami-Mansoor S (2024) Potential therapeutic and diagnostic approaches of exosomes in multiple sclerosis pathophysiology. Life Sci 347:122668","journal-title":"Life Sci"},{"issue":"7613","key":"1716_CR39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature18928","volume":"535","author":"K Hayakawa","year":"2016","unstructured":"Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C, Ji X, Lo EH (2016) Transfer of mitochondria from astrocytes to neurons after stroke. Nature 535(7613):551\u2013555","journal-title":"Nature"},{"issue":"2","key":"1716_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nrneurol.2017.2","volume":"13","author":"B Hemmer","year":"2017","unstructured":"Hemmer B, M\u00fchlau M (2017) Immune-directed therapies in MS \u2014 efficacy and limitations. Nat Rev Neurol 13(2):72\u201374","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1716_CR41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/brain\/awad332","volume":"147","author":"DM Hermann","year":"2024","unstructured":"Hermann DM, Peruzzotti-Jametti L, Giebel B, Pluchino S (2024) Extracellular vesicles set the stage for brain plasticity and recovery by multimodal signalling. Brain 147(2):372\u2013389","journal-title":"Brain"},{"key":"1716_CR42","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fneur.2020.00674","volume":"11","author":"S Hostenbach","year":"2020","unstructured":"Hostenbach S, Raeymaekers H, Van Schuerbeek P, Vanbinst A-M, Cools W, De Keyser J, D\u2019Haeseleer M (2020) The role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS) trial in multiple sclerosis: insights from negative results. Front Neurol 11:674","journal-title":"Front Neurol"},{"issue":"1","key":"1716_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/v17010132","volume":"17","author":"C-H Huang","year":"2025","unstructured":"Huang C-H, Laurent-Rolle M, Grove TL, Hsu JC-C (2025a) Interferon-Stimulated Genes and Immune Metabolites as Broad-Spectrum Biomarkers for Viral Infections. Viruses 17(1):132","journal-title":"Viruses"},{"issue":"8","key":"1716_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70299","volume":"6","author":"M Huang","year":"2025","unstructured":"Huang M, Long A, Hao L, Shi Z, Zhang M (2025b) Astrocyte in neurological disease: pathogenesis and therapy. MedComm 6(8):e70299","journal-title":"MedComm"},{"key":"1716_CR43","doi-asserted-by":"publisher","DOI":"10.37349\/ent.2025.1004104","author":"N Hu","year":"2025","unstructured":"Hu N, Chen L, Hu G, Ma R (2025) Advancements in extracellular vesicle therapy for neurodegenerative diseases. Explor Neuroprotective Ther. https:\/\/doi.org\/10.37349\/ent.2025.1004104","journal-title":"Explor Neuroprotective Ther"},{"key":"1716_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.diff.2022.10.004","volume":"128","author":"RS Ignarro","year":"2022","unstructured":"Ignarro RS, Bombeiro AL, Chiarotto GB, Cartarozzi LP, de Oliveira Coser L, Ghizoni E, Tedeschi H, Cendes F, Lopes-Cendes I, Rogerio F (2022) Interferon-beta induces major histocompatibility complex of class I (MHC-I) expression and a proinflammatory phenotype in cultivated human astrocytes. Differentiation 128:43\u201356","journal-title":"Differentiation"},{"issue":"8","key":"1716_CR47","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jacc.2020.12.060","volume":"77","author":"G Ikeda","year":"2021","unstructured":"Ikeda G, Santoso MR, Tada Y, Li AM, Vaskova E, Jung J-H, O\u2019Brien C, Egan E, Ye J, Yang PC (2021) Mitochondria-rich extracellular vesicles from autologous stem cell\u2013derived cardiomyocytes restore energetics of ischemic myocardium. J Am Coll Cardiol 77(8):1073\u20131088","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1716_CR48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12967-024-05047-4","volume":"22","author":"R Iorio","year":"2024","unstructured":"Iorio R, Petricca S, Mattei V, Delle Monache S (2024) Horizontal mitochondrial transfer as a novel bioenergetic tool for mesenchymal stromal\/stem cells: molecular mechanisms and therapeutic potential in a variety of diseases. J Transl Med 22(1):491","journal-title":"J Transl Med"},{"issue":"10","key":"1716_CR49","doi-asserted-by":"publisher","first-page":"166484","DOI":"10.1016\/j.bbadis.2022.166484","volume":"1868","author":"B Jahangiri","year":"2022","unstructured":"Jahangiri B, Saei AK, Obi PO, Asghari N, Lorzadeh S, Hekmatirad S, Rahmati M, Velayatipour F, Asghari MH, Saleem A (2022) Exosomes, autophagy and ER stress pathways in human diseases: Cross-regulation and therapeutic approaches. Biochim et Biophys Acta (BBA)-Molecular Basis Dis 1868(10):166484","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Basis Dis"},{"key":"1716_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-025-01875-9","author":"A Kadowaki","year":"2025","unstructured":"Kadowaki A, Wheeler MA, Li Z, Andersen BM, Lee H-G, Illouz T, Lee J-H, Ndayisaba A, Zandee SE, Basu H (2025) CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model. Nat Neurosci. https:\/\/doi.org\/10.1038\/s41593-025-01875-9","journal-title":"Nat Neurosci"},{"issue":"4","key":"1716_CR51","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","volume":"56","author":"HI Kim","year":"2024","unstructured":"Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D (2024) Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med 56(4):836\u2013849","journal-title":"Exp Mol Med"},{"issue":"3","key":"1716_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12195-016-0457-4","volume":"9","author":"TN Lamichhane","year":"2016","unstructured":"Lamichhane TN, Jeyaram A, Patel DB, Parajuli B, Livingston NK, Arumugasaamy N, Schardt JS, Jay SM (2016) Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication. Cell Mol Bioeng 9(3):315\u2013324","journal-title":"Cell Mol Bioeng"},{"issue":"2","key":"1716_CR53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5483\/BMBRep.2022-0108","volume":"56","author":"E-H Lee","year":"2023","unstructured":"Lee E-H, Kim M, Ko SH, Kim C-H, Lee M, Park C-H (2023) Primary astrocytic mitochondrial transplantation ameliorates ischemic stroke. BMB Rep 56(2):90","journal-title":"BMB Rep"},{"issue":"1","key":"1716_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/cells8010065","volume":"8","author":"D-S Lin","year":"2019","unstructured":"Lin D-S, Huang Y-W, Ho C-S, Hung P-L, Hsu M-H, Wang T-J, Wu T-Y, Lee T-H, Huang Z-D, Chang P-C (2019) Oxidative insults and mitochondrial DNA mutation promote enhanced autophagy and mitophagy compromising cell viability in pluripotent cell model of mitochondrial disease. Cells 8(1):65","journal-title":"Cells"},{"key":"1716_CR57","doi-asserted-by":"publisher","first-page":"113680","DOI":"10.1016\/j.biopha.2022.113680","volume":"154","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang X, Wang H (2022) The cGAS-STING-mediated NLRP3 inflammasome is involved in the neurotoxicity induced by manganese exposure. Biomed Pharmacother 154:113680","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1716_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12964-023-01466-w","volume":"22","author":"J Liu","year":"2024","unstructured":"Liu J, Zhou J, Luan Y, Li X, Meng X, Liao W, Tang J, Wang Z (2024) cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation. Cell Commun Sig 22(1):22","journal-title":"Cell Commun Sig"},{"key":"1716_CR59","doi-asserted-by":"publisher","first-page":"1562344","DOI":"10.3389\/fcell.2025.1562344","volume":"13","author":"N Liu","year":"2025","unstructured":"Liu N, Liu Y, Wang Y, Feng C, Piao M, Liu M (2025) Oxidative cell death in the central nervous system: mechanisms and therapeutic strategies. Front Cell Dev Biology 13\u20131562344","journal-title":"Front Cell Dev Biology"},{"issue":"2","key":"1716_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/svn-2023-002320","volume":"9","author":"W Li","year":"2024","unstructured":"Li W, Shen N, Kong L, Huang H, Wang X, Zhang Y, Wang G, Xu P, Hu W (2024) STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke. Stroke Vasc Neurol 9(2):153\u2013164","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"1716_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12951-021-00986-2","volume":"19","author":"Y-J Li","year":"2021","unstructured":"Li Y-J, Wu J-Y, Liu J, Xu W, Qiu X, Huang S, Hu X-B, Xiang D-X (2021) Artificial exosomes for translational nanomedicine. J Nanobiotechnol 19(1):242","journal-title":"J Nanobiotechnol"},{"issue":"29","key":"1716_CR60","doi-asserted-by":"publisher","first-page":"eadt1318","DOI":"10.1126\/sciadv.adt1318","volume":"11","author":"P Lou","year":"2025","unstructured":"Lou P, Zhou X, Zhang Y, Xie Y, Wang Y, Wang C, Liu S, Wan M, Lu Y, Liu J (2025) Harnessing tissue-derived mitochondria-rich extracellular vesicles (Ti-mitoEVs) to boost mitochondrial biogenesis for regenerative medicine. Sci Adv 11(29):eadt1318","journal-title":"Sci Adv"},{"issue":"16","key":"1716_CR108","doi-asserted-by":"publisher","first-page":"12912","DOI":"10.3390\/ijms241612912","volume":"24","author":"E L\u00f3pez-Muguruza","year":"2023","unstructured":"L\u00f3pez-Muguruza E, Matute C (2023) Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis. Int J Mol Sci 24(16):12912","journal-title":"Int J Mol Sci"},{"issue":"supplement 2","key":"1716_CR61","first-page":"242590","volume":"65","author":"A Madani Neishaboori","year":"2024","unstructured":"Madani Neishaboori A, Agarwal M, Lofaso J, Rampilla G, Chaney A, Kras E, Kulkarni A (2024) Is TSPO PET imaging in multiple sclerosis supported by the existing evidence? A systematic review and meta-analysis. J Nucl Med 65(supplement 2):242590\u2013242590","journal-title":"J Nucl Med"},{"issue":"Pt 7","key":"1716_CR62","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awn105","volume":"131","author":"D Mahad","year":"2008","unstructured":"Mahad D, Ziabreva I, Lassmann H, Turnbull D (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131(Pt 7):1722\u20131735","journal-title":"Brain"},{"issue":"6","key":"1716_CR63","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.medj.2024.03.018","volume":"5","author":"M Maimaiti","year":"2024","unstructured":"Maimaiti M, Li C, Cheng M, Zhong Z, Hu J, Yang L, Zhang L, Hong Z, Song J, Pan M (2024) Blocking cGAS-STING pathway promotes post-stroke functional recovery in an extended treatment window via facilitating remyelination. Med 5(6):622\u2013644 e628","journal-title":"Med"},{"issue":"3","key":"1716_CR64","first-page":"e200100","volume":"10","author":"S Malhotra","year":"2023","unstructured":"Malhotra S, Hurtado-Navarro L, Pappolla A, Villar LM, R\u00edo J, Montalban X, Pelegrin P, Comabella M (2023) Increased NLRP3 inflammasome activation and pyroptosis in patients with multiple sclerosis with fingolimod treatment failure. Neurology: Neuroimmunol Neuroinflammation 10(3):e200100","journal-title":"Neurol: Neuroimmunol Neuroinflamm"},{"issue":"6","key":"1716_CR65","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1007\/s12035-024-04412-0","volume":"62","author":"Y Mishra","year":"2025","unstructured":"Mishra Y, Kumar A, Kaundal RK (2025) Mitochondrial dysfunction is a crucial immune checkpoint for neuroinflammation and neurodegeneration: mtdamps in focus. Mol Neurobiol 62(6):6715\u20136747","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1716_CR66","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1038\/s41467-019-12382-4","volume":"10","author":"S Modi","year":"2019","unstructured":"Modi S, L\u00f3pez-Dom\u00e9nech G, Halff EF, Covill-Cooke C, Ivankovic D, Melandri D, Arancibia-C\u00e1rcamo IL, Burden JJ, Lowe AR, Kittler JT (2019) Miro clusters regulate ER-mitochondria contact sites and link cristae organization to the mitochondrial transport machinery. Nat Commun 10(1):4399","journal-title":"Nat Commun"},{"issue":"6","key":"1716_CR67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/imcb.12555","volume":"100","author":"K Mosallanejad","year":"2022","unstructured":"Mosallanejad K, Kagan JC (2022) Control of innate immunity by the cGAS-STING pathway. Immunol Cell Biol 100(6):409\u2013423","journal-title":"Immunol Cell Biol"},{"key":"1716_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X251325805","author":"S Mozafari","year":"2025","unstructured":"Mozafari S, Peruzzotti-Jametti L, Pluchino S (2025) Mitochondria transfer for myelin repair. J Cereb Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678X251325805","journal-title":"J Cereb Blood Flow Metab"},{"key":"1716_CR69","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X241300223","author":"T Nakano","year":"2024","unstructured":"Nakano T, Irie K, Matsuo K, Mishima K, Nakamura Y (2024) Molecular and cellular mechanisms of mitochondria transfer in models of central nervous system disease. J Cereb Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678X241300223","journal-title":"J Cereb Blood Flow Metab"},{"key":"1716_CR70","doi-asserted-by":"publisher","first-page":"116429","DOI":"10.1016\/j.jns.2019.116429","volume":"405","author":"S Nohara","year":"2019","unstructured":"Nohara S, Ishii A, Yamamoto F, Yanagiha K, Moriyama T, Tozaka N, Miyake Z, Yatsuga S, Koga Y, Hosaka T (2019) GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis. J Neurol Sci 405:116429","journal-title":"J Neurol Sci"},{"issue":"12","key":"1716_CR71","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.3390\/ijms22126352","volume":"22","author":"E Obrador","year":"2021","unstructured":"Obrador E, Salvador-Palmer R, L\u00f3pez-Blanch R, Jihad-Jebbar A, Vall\u00e9s SL, Estrela JM (2021) The link between oxidative stress, redox status, bioenergetics and mitochondria in the pathophysiology of ALS. Int J Mol Sci 22(12):6352","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1716_CR72","doi-asserted-by":"publisher","first-page":"37889","DOI":"10.1038\/srep37889","volume":"6","author":"S Oka","year":"2016","unstructured":"Oka S, Leon J, Sakumi K, Ide T, Kang D, LaFerla FM, Nakabeppu Y (2016) Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer\u2019s disease. Sci Rep 6(1):37889","journal-title":"Sci Rep"},{"key":"1716_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s13770-025-00726-9","author":"H Park","year":"2025","unstructured":"Park H, Seo Y-K, Arai Y, Lee S-H (2025) Physicochemical modulation strategies for mass production of extracellular vesicle. Tissue Eng Regen Med. https:\/\/doi.org\/10.1007\/s13770-025-00726-9","journal-title":"Tissue Eng Regen Med"},{"key":"1716_CR74","doi-asserted-by":"publisher","first-page":"811518","DOI":"10.3389\/fneur.2021.811518","volume":"12","author":"O Perdaens","year":"2022","unstructured":"Perdaens O, Van Pesch V (2022) Molecular mechanisms of immunosenescene and inflammaging: relevance to the immunopathogenesis and treatment of multiple sclerosis. Front Neurol 12:811518","journal-title":"Front Neurol"},{"key":"1716_CR75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2025.06.040","volume":"238","author":"Q Perrier","year":"2025","unstructured":"Perrier Q, Lisi V, Fisherwellman K, Lablanche S, Asthana A, Orlando G, Maiocchi S (2025) Therapeutic transplantation of mitochondria and extracellular vesicles: mechanistic insights into mitochondria bioenergetics, redox signaling, and organelle dynamics in preclinical models. Free Radic Biol Med 238:473\u2013495","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"1716_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001166","volume":"19","author":"L Peruzzotti-Jametti","year":"2021","unstructured":"Peruzzotti-Jametti L, Bernstock JD, Willis CM, Manferrari G, Rogall R, Fernandez-Vizarra E, Williamson JC, Braga A, van den Bosch A, Leonardi T (2021) Neural stem cells traffic functional mitochondria via extracellular vesicles. PLoS Biol 19(4):e3001166","journal-title":"PLoS Biol"},{"issue":"1","key":"1716_CR77","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1038\/ncomms9472","volume":"6","author":"DG Phinney","year":"2015","unstructured":"Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, Stolz DB, Watkins SC, Di YP, Leikauf GD (2015) Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 6(1):8472","journal-title":"Nat Commun"},{"key":"1716_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042245","author":"P Picone","year":"2022","unstructured":"Picone P, Nuzzo D (2022) Promising treatment for multiple sclerosis: mitochondrial transplantation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23042245","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1716_CR79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/BCJ20200710","volume":"478","author":"G Pinto","year":"2021","unstructured":"Pinto G, Saenz-de-Santa-Maria I, Chastagner P, Perthame E, Delmas C, Toulas C, Moyal-Jonathan-Cohen E, Brou C, Zurzolo C (2021) Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids. Biochem J 478(1):21\u201339","journal-title":"Biochem J"},{"key":"1716_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00085","volume":"9","author":"P Poutiainen","year":"2016","unstructured":"Poutiainen P, Jaronen M, Quintana FJ, Brownell AL (2016) Precision medicine in multiple sclerosis: future of PET imaging of inflammation and reactive astrocytes. Front Mol Neurosci 9:85","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"1716_CR81","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/14737175.2014.890893","volume":"14","author":"AD Pusic","year":"2014","unstructured":"Pusic AD, Pusic KM, Kraig RP (2014) What are exosomes and how can they be used in multiple sclerosis therapy? Expert Rev Neurother 14(4):353\u2013355","journal-title":"Expert Rev Neurother"},{"key":"1716_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.752019","volume":"9","author":"H Qi","year":"2021","unstructured":"Qi H, Wang Y, Fa S, Yuan C, Yang L (2021) Extracellular vesicles as natural delivery carriers regulate oxidative stress under pathological conditions. Front Bioeng Biotechnol 9:752019","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"1716_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3892\/ijmm.2024.5371","volume":"53","author":"P Qin","year":"2024","unstructured":"Qin P, Sun Y, Li L (2024) Mitochondrial dysfunction in chronic neuroinflammatory diseases. Int J Mol Med 53(5):47","journal-title":"Int J Mol Med"},{"issue":"3","key":"1716_CR84","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2478\/enr-2022-0025","volume":"56","author":"V Rambani","year":"2022","unstructured":"Rambani V, Hromnikova D, Gasperikova D, Skopkova M (2022) Mitochondria and mitochondrial disorders: an overview update. Endocr Regul 56(3):232\u2013248","journal-title":"Endocr Regul"},{"issue":"6","key":"1716_CR85","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","volume":"13","author":"M Riazifar","year":"2019","unstructured":"Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lasser C, Segaliny AI, McIntyre LL, Shelke GV, Hutchins E, Hamamoto A (2019) Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano 13(6):6670\u20136688","journal-title":"ACS Nano"},{"issue":"1","key":"1716_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/srep33249","volume":"6","author":"M Sadeghian","year":"2016","unstructured":"Sadeghian M, Mastrolia V, Rezaei Haddad A, Mosley A, Mullali G, Schiza D, Sajic M, Hargreaves I, Heales S, Duchen MR, Smith KJ (2016) Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Rep 6(1):33249","journal-title":"Sci Rep"},{"issue":"43","key":"1716_CR87","doi-asserted-by":"publisher","first-page":"E9066","DOI":"10.1073\/pnas.1704862114","volume":"114","author":"P Sansone","year":"2017","unstructured":"Sansone P, Savini C, Kurelac I, Chang Q, Amato LB, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly L (2017) Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci 114(43):E9066\u2013E9075","journal-title":"Proc Natl Acad Sci"},{"key":"1716_CR88","doi-asserted-by":"publisher","first-page":"1413843","DOI":"10.3389\/fncel.2024.1413843","volume":"18","author":"SIP Santos","year":"2024","unstructured":"Santos SIP, Ortiz-Pe\u00f1uela SJ, de Paula Filho A, Tomiyama ALMR, Coser LdO, da Silveira JC, Martins DdS, Ciena AP, de Oliveira ALR, Ambr\u00f3sio CE (2024) Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation. Front Cell Neurosci 18:1413843","journal-title":"Front Cell Neurosci"},{"issue":"18","key":"1716_CR89","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","volume":"112","author":"H Scheiblich","year":"2024","unstructured":"Scheiblich H, Eikens F, Wischhof L, Opitz S, J\u00fcngling K, Cser\u00e9p C, Schmidt SV, Lambertz J, Bellande T, P\u00f3sfai B (2024) Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes. Neuron 112(18):3106\u20133125 e3108","journal-title":"Neuron"},{"issue":"4","key":"1716_CR90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.55133\/eji.300413","volume":"30","author":"RM Sedky","year":"2023","unstructured":"Sedky RM, Zaki MM, Mahmoud ME, Hassan SH, Khater SS, Abou Zaghla HMA (2023) Mitochondrial DNA copy number as a biomarker of multiple sclerosis. Egypt J Immunol 30(4):121\u2013133","journal-title":"Egypt J Immunol"},{"issue":"9","key":"1716_CR91","doi-asserted-by":"publisher","first-page":"e70597","DOI":"10.1111\/cns.70597","volume":"31","author":"V Shi","year":"2025","unstructured":"Shi V, Wu S, Lian Q, Shi R, Liu Z, Xu T, Deng S, Shao X, Beckmann A, Li W (2025) Dual-Functionalized Extracellular Vesicles Promote Brain Repair and Remodeling Following Ischemic Stroke in Mice. CNS Neurosci Ther 31(9):e70597","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"1716_CR92","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/glia.24648","volume":"73","author":"AL Soung","year":"2025","unstructured":"Soung AL, Kyauk RV, Pandey S, Shen YAA, Reichelt M, Lin H, Jiang Z, Kirshnamoorthy P, Foreman O, Lauffer BE (2025) Modulation of OPC mitochondrial function by inhibiting USP30 promotes their differentiation. Glia 73(4):773\u2013787","journal-title":"Glia"},{"issue":"6","key":"1716_CR93","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-024-12329-w","volume":"271","author":"H Tao","year":"2024","unstructured":"Tao H, Gao B (2024) Exosomes for neurodegenerative diseases: diagnosis and targeted therapy. J Neurol 271(6):3050\u20133062","journal-title":"J Neurol"},{"issue":"1","key":"1716_CR94","volume":"2020","author":"MJ Tavassolifar","year":"2020","unstructured":"Tavassolifar MJ, Moghadasi AN, Esmaeili B, Sadatpour O, Vodjgani M, Izad M (2020) Redox imbalance in CD4\u2009+\u2009T cells of relapsing-remitting multiple sclerosis patients. Oxid Med Cell Longev 2020(1):8860813","journal-title":"Oxid Med Cell Longev"},{"key":"1716_CR95","doi-asserted-by":"publisher","first-page":"870193","DOI":"10.3389\/fbioe.2022.870193","volume":"10","author":"MA Thomas","year":"2022","unstructured":"Thomas MA, Fahey MJ, Pugliese BR, Irwin RM, Antonyak MA, Delco ML (2022) Human mesenchymal stromal cells release functional mitochondria in extracellular vesicles. Front Bioeng Biotechnol 10:870193","journal-title":"Front Bioeng Biotechnol"},{"key":"1716_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17080990","author":"N Verma","year":"2025","unstructured":"Verma N, Arora S (2025) Navigating the global regulatory landscape for exosome-based therapeutics: challenges, strategies, and future directions. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics17080990","journal-title":"Pharmaceutics"},{"issue":"1","key":"1716_CR97","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1038\/s41467-024-52444-w","volume":"15","author":"LJ Wagstaff","year":"2024","unstructured":"Wagstaff LJ, Bestard-Cuche N, Kaczmarek M, Fidanza A, McNeil L, Franklin RJM, Williams AC (2024) CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents. Nat Commun 15(1):8570","journal-title":"Nat Commun"},{"key":"1716_CR98","doi-asserted-by":"publisher","first-page":"105020","DOI":"10.1016\/j.msard.2023.105020","volume":"79","author":"Q Wang","year":"2023","unstructured":"Wang Q, Wu Q, Yang J, Saad A, Mills E, Dowling C, Lundy S, Mao-Draayer Y (2023a) Dysregulation of humoral immunity, iron homeostasis, and lipid metabolism is associated with multiple sclerosis progression. Multiple Scler Relat Disorders 79:105020","journal-title":"Multiple Scler Relat Disorders"},{"key":"1716_CR99","doi-asserted-by":"publisher","first-page":"110835","DOI":"10.1016\/j.intimp.2023.110835","volume":"124","author":"Y-K Wang","year":"2023","unstructured":"Wang Y-K, Zhao Y-p, Ye M-Z, Wang L, Lan T-S, Wang Y, Qi Z-Q (2023b) Chimeric CNS-targeting-peptide engineered exosomes for experimental autoimmune encephalomyelitis therapy. Int Immunopharmacol 124:110835","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1716_CR100","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DC, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TA, Erdbr\u00fcgger U (2024) Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell vesicles 13(2):e12404","journal-title":"J Extracell vesicles"},{"issue":"9","key":"1716_CR101","doi-asserted-by":"publisher","first-page":"e12343","DOI":"10.1002\/jev2.12343","volume":"12","author":"JA Whitley","year":"2023","unstructured":"Whitley JA, Cai H (2023) Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing. J Extracell Vesicles 12(9):e12343","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"1716_CR102","doi-asserted-by":"publisher","first-page":"e23068","DOI":"10.1096\/fj.202300573R","volume":"37","author":"K Zamiri","year":"2023","unstructured":"Zamiri K, Kesari S, Paul K, Hwang SH, Hammock B, Kaczor-Urbanowicz KE, Urbanowicz A, Gao L, Whitelegge J, Fiala M (2023) Therapy of autoimmune inflammation in sporadic amyotrophic lateral sclerosis: Dimethyl fumarate and H\u2010151 downregulate inflammatory cytokines in the cGAS\u2010STING pathway. FASEB J 37(8):e23068","journal-title":"FASEB J"},{"issue":"19","key":"1716_CR103","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1039\/D2BM00518B","volume":"10","author":"Y Zhai","year":"2022","unstructured":"Zhai Y, Wang Q, Zhu Z, Hao Y, Han F, Hong J, Zheng W, Ma S, Yang L, Cheng G (2022) High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination. Biomater Sci 10(19):5707\u20135718","journal-title":"Biomater Sci"},{"key":"1716_CR104","doi-asserted-by":"publisher","first-page":"113895","DOI":"10.1016\/j.expneurol.2021.113895","volume":"347","author":"J Zhang","year":"2022","unstructured":"Zhang J, Buller BA, Zhang ZG, Zhang Y, Lu M, Rosene DL, Medalla M, Moore TL, Chopp M (2022) Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol 347:113895","journal-title":"Exp Neurol"},{"key":"1716_CR105","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jconrel.2024.10.033","volume":"376","author":"L Zhang","year":"2024","unstructured":"Zhang L, Lin J, Xiang K, Shi T, Guo B (2024) Omnidirectional improvement of mitochondrial health in Alzheimer\u2019s disease by multi-targeting engineered activated neutrophil exosomes. J Control Release 376:470\u2013487","journal-title":"J Control Release"},{"issue":"1","key":"1716_CR106","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12967-025-06283-y","volume":"23","author":"M Zhao","year":"2025","unstructured":"Zhao M, Wang J, Zhu S, Zhang S, Han C, Tan C, Huang Y, Sun Z, Wang L, Liu J (2025) Human neural stem cell-derived exosomes activate PINK1\/Parkin pathway to protect against oxidative stress-induced neuronal injury in ischemic stroke. J Translational Med 23(1):402","journal-title":"J Translational Med"},{"key":"1716_CR107","doi-asserted-by":"publisher","first-page":"111256","DOI":"10.1016\/j.brainresbull.2025.111256","volume":"222","author":"AM Zonouz","year":"2025","unstructured":"Zonouz AM, Rahbardar MG, Alibolandi M (2025) Exosome-based platforms for treatment of multiple sclerosis. Brain Res Bull 222:111256","journal-title":"Brain Res Bull"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01716-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:17:50Z","timestamp":1781648270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01716-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01716-8","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"95"}}